Arkolith/Insider Trading/TXG/Form 4

Hindson Benjamin J.

See Remarks, Director10x Genomics, Inc. (TXG) · full profile →Form 4 · filed Dec 29, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 28, 2023Option exercise(M)8K$11.48$96K286K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 28, 2023Option exercise(M)8K—$015K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-23-000427) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML